Previously submitted to: JMIR Research Protocols (no longer under consideration since Dec 14, 2022)
Date Submitted: May 12, 2022
Open Peer Review Period: May 12, 2022 - Jul 7, 2022
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Participation in cancer clinical trials: the role of unrealistic optimism and fear of pain
ABSTRACT
Background:
In a cancer clinical trial, patients with unrealistic optimism expect to experience higher benefits and lower risks compared to other patients who participate in the same trial. Although this finding has been replicated in few cross-sectional studies, there is no experimental evidence on the relationship between unrealistic optimism and intention to participate in trials.
Objective:
The aim of the current project is to analyze unrealistic optimism and fear of pain in an experimental design by creating hypothetical scenarios for healthy participants. Specifically, the primary aim is to replicate the effect of unrealistic optimism in an experimental design demonstrating that this bias is only present when considering one's probability to experience higher benefits and lower risks from an event, compared to others who take part in the same event. Second, we aim to investigate how cognitive (unrealistic optimism, perception of control) and emotional (pain) factors may influence the intention to partake in a clinical trial.
Methods:
A between-subject experimental design has been created. 176 participants will be enrolled and randomly assigned to two experimental conditions (N=88 per condition) in which they have to imagine “self” (condition1) or “person X” (condition2) having cancer and being faced with the decision to partake in an early phase clinical trial. Unrealistic optimism and the intention to take part in the clinical trial will be assessed. Other measures will include perceived controllabilityfear of pain. Corresponding to AIM 1, the two conditions will be compared to see the differences in (1) unrealistic optimism scores and (2) the intention to partake in the clinical trial. Corresponding to AIM 2, the effect of cognitive and emotional factors on the internion to partake in a clinical trial will be tested through a multivariate model.
Results:
We expect participants in condition1 to (a) score higher on unrealistic optimism and to (b) have a higher intention to participate. These results would confirm that unrealistic optimism is observed solely when a trial's outcomes are predicted for oneself rather than for another person. Moreover, we expect a significant effect of perceived controllability and of fear of pain on unrealistic optimism and on the intention to take part in the clinical trials.
Conclusions:
This study will provide important insights into the processes that lead people to participate in early phase cancer clinical trials. More specifically, the results will provide useful elements for helping the professionals and patients in the decision-making process, understanding barriers/facilitators in the decision to partake in an early phase clinical trial. Additionally, in respect to previous research, the experimental design gives this study a methodological advantage. By adapting hypothetical scenarios, we hope to encourage other researchers in the field to utilize perspective-taking of healthy participants, alongside studying patients.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.